Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-100
SponsorHelsinki University Central Hospital

About this trial

The purpose of this study is to assess whether deep sclerectomy is as effective in lowering intraocular pressure (IOP) as trabeculectomy in patients with normal tension glaucoma.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Signed Informed Consent

Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs and/or optical coherence tomography (OCT) and possible equivalent visual field defects, IOP never more than 21 mmHg, and open anterior chamber angle

Glaucoma unstable with current medication assessed by a glaucoma specialist

Disqualifiers

Secondary Glaucoma e.g. due to previous injury or uveitis

Exfoliation syndrome

Pigment dispersion syndrome

Previous transscleral or endoscopic cyclophotocoagulation

Trial design

Design model

Single group

Treatments tested in this trial

  • Trabeculectomy

    Procedure/Surgery

    trabeculectomy glaucoma surgery

  • Deep Sclerectomy

    Procedure/Surgery

    deep sclerectomy glaucoma surgery

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Deep sclerectomyExperimental treatment 1 intervention
Group B: TrabeculectomyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Success Rate

Decrease in Intraocular Pressure of 20 % or more or former level with fewer medications

Time frame
One year

Secondary outcomes

1

Success Rate

Decrease in Intraocular Pressure of 20 % or more or former level with fewer medications

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.